VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tunica Albuginea who wrote (4418)	1/8/1998 7:29:00 PM
From: BigKNY3	Read Replies (1) of 23519

TA: Gee, here you had me all convinced that physicians are only concerned about "patient concerns" and remain unbiased due to financial considerations.....Does this now apply to physicians who own stock in pharmaceutical companies? Should we demand full disclosure on our posts? What was missing from the Toronto study was an analysis of the payments made to the calcium channel blocker critics by competitive antihypertensive companies. I bet it would have been very revealing. Basically, the study revealed nothing new. The pharmaceutical industry supports the leaders in the field and investigators who agree with their point of view. Hard to debate this logic. BigKNY3 Full Disclosure: Own stock in VVUS, PFE, WLA, MRK, LLY, & AMGN

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next